Research ExplorerPublicationsHautersatzverfahren bei chronischen Wunden

Hautersatzverfahren bei chronischen Wunden

Standard

Hautersatzverfahren bei chronischen Wunden. / Ziegler, U E; Debus, E S; Keller, H P; Thiede, A.

In: ZBL CHIR, Vol. 126 Suppl 1, 2001, p. 71-74.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Ziegler, UE, Debus, ES, Keller, HP & Thiede, A 2001, 'Hautersatzverfahren bei chronischen Wunden', ZBL CHIR, vol. 126 Suppl 1, pp. 71-74. https://doi.org/10.1055/s-2001-19205

APA

Ziegler, U. E., Debus, E. S., Keller, H. P., & Thiede, A. (2001). Hautersatzverfahren bei chronischen Wunden. ZBL CHIR, 126 Suppl 1, 71-74. https://doi.org/10.1055/s-2001-19205

Vancouver

Ziegler UE, Debus ES, Keller HP, Thiede A. Hautersatzverfahren bei chronischen Wunden. ZBL CHIR. 2001;126 Suppl 1:71-74. https://doi.org/10.1055/s-2001-19205

Bibtex

@article{6a741ca59ee44d44828f23d56084029f,
title = "Hautersatzverfahren bei chronischen Wunden",
abstract = "Skin substitutes in chronic wounds. There is a large demand for skin substitutes for the coverage of chronic wounds. Due to a intensive and local wound treatment the impaired dermal and epidermal repair still remains a major problem. Known treatmentes as split-skin-, reverdin- and pinch grafts make a sufficient and solid wound closure possible. However in such procedures the take rate of grafting often failes. The graft healing is increased with combined mesh-graft and vacuum-sealing technique. Temporary and permanent skin substitutes extend the spectrum in closure of chronic defects. Sheets and single cell suspensions of keratinocytes are available for clincial treatments. First clinical results with autologous keratinocyte transplantation are described. In the future approaches in gen therapy becomes more and more important for skin substitutes.",
keywords = "Chronic Disease, Humans, Keratinocytes/transplantation, Skin Transplantation, Skin, Artificial, Tissue Engineering, Transplantation, Autologous, Wounds and Injuries/surgery",
author = "Ziegler, {U E} and Debus, {E S} and Keller, {H P} and A Thiede",
year = "2001",
doi = "10.1055/s-2001-19205",
language = "Deutsch",
volume = "126 Suppl 1",
pages = "71--74",
journal = "ZBL CHIR",
issn = "0044-409X",
publisher = "Georg Thieme Verlag KG",

}

RIS

TY - JOUR

T1 - Hautersatzverfahren bei chronischen Wunden

AU - Ziegler, U E

AU - Debus, E S

AU - Keller, H P

AU - Thiede, A

PY - 2001

Y1 - 2001

N2 - Skin substitutes in chronic wounds. There is a large demand for skin substitutes for the coverage of chronic wounds. Due to a intensive and local wound treatment the impaired dermal and epidermal repair still remains a major problem. Known treatmentes as split-skin-, reverdin- and pinch grafts make a sufficient and solid wound closure possible. However in such procedures the take rate of grafting often failes. The graft healing is increased with combined mesh-graft and vacuum-sealing technique. Temporary and permanent skin substitutes extend the spectrum in closure of chronic defects. Sheets and single cell suspensions of keratinocytes are available for clincial treatments. First clinical results with autologous keratinocyte transplantation are described. In the future approaches in gen therapy becomes more and more important for skin substitutes.

AB - Skin substitutes in chronic wounds. There is a large demand for skin substitutes for the coverage of chronic wounds. Due to a intensive and local wound treatment the impaired dermal and epidermal repair still remains a major problem. Known treatmentes as split-skin-, reverdin- and pinch grafts make a sufficient and solid wound closure possible. However in such procedures the take rate of grafting often failes. The graft healing is increased with combined mesh-graft and vacuum-sealing technique. Temporary and permanent skin substitutes extend the spectrum in closure of chronic defects. Sheets and single cell suspensions of keratinocytes are available for clincial treatments. First clinical results with autologous keratinocyte transplantation are described. In the future approaches in gen therapy becomes more and more important for skin substitutes.

KW - Chronic Disease

KW - Humans

KW - Keratinocytes/transplantation

KW - Skin Transplantation

KW - Skin, Artificial

KW - Tissue Engineering

KW - Transplantation, Autologous

KW - Wounds and Injuries/surgery

U2 - 10.1055/s-2001-19205

DO - 10.1055/s-2001-19205

M3 - SCORING: Review

C2 - 11819178

VL - 126 Suppl 1

SP - 71

EP - 74

JO - ZBL CHIR

JF - ZBL CHIR

SN - 0044-409X

ER -